胸部SMARCA4缺陷性未分化肿瘤与SMARCA4缺陷性非小细胞肺癌的细针穿刺及积液细胞学:27例多机构经验
本研究多机构回顾27例胸部SMARCA4缺陷性恶性肿瘤(17例SD-UT,10例SD-NSCLC)的FNA、支气管刷检和胸腔积液细胞学,比较细胞形态与免疫表型。SD-UT多呈黏附松散或混合结构且以横纹肌样或混合横纹肌样-上皮样形态为主,SD-NSCLC多呈黏附性或混合结构且以上皮样形态为主。角蛋白和claudin-4在SD-UT中阴性或局灶阳性,在SD-NSCLC中弥漫阳性;两者TTF-1、p40/p63阴性且SMARCA4表达缺失。
要点
- SD-UT细胞学多黏附松散、横纹肌样或混合横纹肌样-上皮样形态。
- SD-NSCLC多黏附性或混合黏附-松散、以上皮样形态为主。
- 角蛋白和claudin-4在SD-UT阴性或局灶阳性,在SD-NSCLC弥漫阳性。
核心结论
- SD-UT与SD-NSCLC临床和细胞病理有重叠,但关键特征可区分两者。
- 结合临床、细胞形态和免疫组化对明确诊断至关重要。
研究设计与样本
- 多机构回顾性研究,纳入27例胸部SMARCA4缺陷性恶性肿瘤患者。
主要发现
- 两种肿瘤均表现为大胸部肿块和/或肺门/纵隔淋巴结肿大。
- 所有SD-UT细胞学样本呈黏附松散或混合黏附-松散结构,13/17例以横纹肌样或混合横纹肌样-上皮样形态为主。
- 9/10例SD-NSCLC细胞学样本呈黏附性或混合黏附-松散结构,8/10例以上皮样形态为主。
- 角蛋白和claudin-4在SD-UT样本中阴性或局灶阳性,在SD-NSCLC样本中弥漫阳性。
- 两种肿瘤均TTF-1和p40/p63阴性,且SMARCA4表达缺失。
临床怎么用
- 细胞学评估胸部SMARCA4缺陷性肿瘤时,应结合黏附结构、细胞形态和免疫组化(角蛋白、claudin-4、TTF-1、p40/p63、SMARCA4)综合判断。
- SD-UT与SD-NSCLC的区分需依赖细胞形态与免疫表型组合,避免单一特征误判。
局限性
- 样本量较小(27例),且为回顾性多机构研究。
- 细胞学标本类型包括FNA、支气管刷检和胸腔积液,数量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic switch/sucrose nonfermentable-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4)-deficient (SD) malignancies, including SD undifferentiated tumor (SD-UT) and SD non-small cell lung carcinoma (SD-NSCLC), have been recently described. The cytologic features of these neoplasms in fine-needle aspiration (FNA) and effusion specimens have rarely been reported in the literature. This study aimed to describe and compare the spectrum of cytologic, immunohistochemical, and clinical features of these high-grade malignancies recently encountered at the participating institutions. METHODS: This study documented clinical and imaging characteristics of tumors from 27 patients. Sixteen cytomorphologic features and immunohistochemical findings were compared between SD-UT and SD-NSCLC samples. RESULTS: Twenty three FNAs, two bronchial brushings, and two pleural fluids were evaluated, including 17 SD-UT cases (mean patient age, 70 years) and 10 SD-NSCLC cases (mean patient age, 62 years). Both malignancies presented with large thoracic masses and/or hilar/mediastinal lymphadenopathy. All SD-UT cytologic samples had a discohesive or mixed cohesive-discohesive architecture, and most (13 of 17) showed predominant rhabdoid or mixed rhabdoid-epithelioid features. Most SD-NSCLC cytologic samples (nine of 10) were either cohesive or mixed cohesive-discohesive and had a predominantly epithelioid morphology (eight of 10). Keratins and claudin-4 were negative or focally positive in SD-UT samples, whereas they were diffusely positive in SD-NSCLC samples. Both malignancies were negative for TTF-1 and p40/p63 and showed loss of expression of SMARCA4. CONCLUSIONS: Although there is considerable clinical and cytopathologic overlap between SD-UT and SD-NSCLC, some key features allow for their distinction. SD-UT is mostly discohesive with rhabdoid or mixed rhabdoid-epithelioid features, whereas SD-NSCLC often has cohesive epithelioid morphology. The combination of clinical presentation, cytomorphology, and immunohistochemistry is essential for a definitive diagnosis.
引用
- Zalles N, Mukhopadhyay S, Satturwar S, et al. Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: A multi-institutional experience with 27 patients. Cancer Cytopathol. 2024. PMID: 39555952. doi:10.1002/cncy.22919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。